David Muhlestein co-authors a new study on Medicare ACO attribution methods

AJMC: David Muhlestein, chief strategy and chief research officer for Leavitt Partners, recently co-authored a study on Medicare accountable care organization (ACO) attribution methods. The study examines patient survival rates and spending by Medicare for ACO populations based on whether the ACOs use prospective or retrospective claims-based attribution methods. Read the full article here.